Hua Xia Healthcare Holdings Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hua Xia Healthcare Holdings Limited with three other
drug stores in Asia:
Hai-O Enterprise Berhad
sales of 297.63 million Malaysian Ringgits [US$66.69 million]
of which 67%
was Multi-Level Marketing),
Extrawell Pharmaceutical Holdings Limited
(142.20 million Hong Kong Dollars [US$18.33 million]
of which 70%
was Trading), and
Hin Sang Group International Holding Co Ltd
(227.46 million Hong Kong Dollars [US$29.33 million]
of which 81%
was Product Development Segment).
Hua Xia Healthcare Holdings Limited reported sales of HK$1.57 billion (US$203.01 million)
March of 2016.
decrease of 11.6%
versus 2015, when the company's sales were HK$1.78 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Hua Xia Healthcare Holdings Limited had sales
of HK$1.49 billion.
Contributing to the drop in overall sales was the 15.6% decline
in Pharmaceutical Wholesale, from HK$1.57 billion to HK$1.32 billion.
However, these declines were partially offset by the increase in sales of
Provision of General Hospital Services (up 18.1% to HK$252.84 million)